Table 2 Previously reported cases of PEG-associated vasculitis
Reference | Year | Age (years) | Sex | Primary disease | Symptoms | CRP (mg/dL) | Time between PEG administration and symptoms (days) | Location of vasculitis | Diagnostic modality | Steroid | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Other | ||||||||||
Koyama et al. [19] | 2021 | 43 | F | Breast cancer | + | 27.1 | 5 | Arch/TA | CT | PSL 60 mg | |
Fujiwara et al. [20] | 2021 | 66 | F | Colon cancer | + | Back pain | 20.2 | 2 | Arch/TA, SCA | CT | PSL 30 mg |
Kametani et al. [21] | 2021 | 56 | M | Mucinous chondrosarcoma | + | General fatigue, rash with pain | 38.8 | 4 | Arch/TA | CT | PSL 60 mg |
Saito et al. [22] | 2021 | 71 | F | Intrahepatic cholangiocarcinoma | + | Back pain, chest pain | 18.9 | 7 | Arch/TA | CT | PSL 30 mg |
Jimbo et al. [1] | 2021 | 58 | F | Breast cancer | + | 13.7 | 8 | SCA | CT | None | |
Lee et al. [7] | 2020 | 66 | F | Breast cancer | + | Myalgia, chills, nausea | 26.6 | 13 | Arch/TA, AA, CCA, innominate artery | CT | PSL 0.5 mg/kg |
49 | F | Breast cancer | + | Myalgia, chest discomfort, dyspepsia | 21.8 | 15 | Arch/TA, CCA | CT, PET/CT | PSL 0.5 mg/kg | ||
50 | F | Breast cancer | + | Myalgia, chills | 29.6 | 12 | Arch/TA, CCA, SCA, innominate artery | CT | PSL 0.5 mg/kg | ||
59 | F | Breast cancer | + | Myalgia, chills | 32.9 | 17 | Arch/TA, AA, CCA, innominate artery | CT | PSL 0.5 mg/kg | ||
53 | F | Breast cancer | + | Myalgia, chills, headache | 10.9 | 14 | Arch/TA, CCA | CT | PSL 0.5 mg/ kg | ||
Nakamura et al. [23] | 2020 | 66 | F | Breast cancer | + | Left anterior neck pain | 8.2 | 11 | CCA | CT | None |
Mukai et al. [24] | 2020 | 66 | F | Breast cancer | + | Malaise, abdominal discomfort | 20.4 | 10 | Arch/TA, AA | CT, MRI | PSL 55 mg |
Taimen et al. [8] | 2020 | 53 | F | Breast cancer | + | Chest pain, sore throat, earache, dyspnea | Unknown | 1 | Arch/TA | CT, MRI | Corticosteroid |
Miyazaki et al. [25] | 2020 | 65 | F | Pancreatic cancer | + | 8 | Arch/TA | CT | None | ||
Hoshina et al. [26] | 2019 | 72 | F | Breast cancer | + | 46.4 | 4 | Arch/TA | PET/CT | None | |
Yukawa et al. [27] | 2019 | 71 | F | Endometrial cancer | + | 27.9 | 4 | Arch/TA | CT | PSL 60 mg | |
Sasaki et al. [28] | 2019 | 69 | M | Non-Hodgkin lymphoma | + | 21.4 | 13 | SCA | CT | None | |
Lardieri et al. [29] | 2018 | 72 | F | Uterine cancer | Cough, lumbar and back pain | 30.1 | 13 | Aorta | CT | None | |
76 | F | Breast cancer | + | Precordial pain | 35.9 | 7 | Aorta | CT | None | ||
61 | F | Breast cancer | + | Left neck pain | 25.4 | 7 | Aorta | CT, MRI | None | ||
65 | F | Breast cancer | + | Chest tightness, cough | 30.8 | 9 | Aorta | CT | Steroid | ||
66 | M | Prostate cancer | + | 33.3 | 8 | Aorta | CT | None | |||
69 | F | Esophageal cancer | + | 11 | Aorta | CT, US | None | ||||
Sato et al. [6] | 2017 | 67 | F | Lung cancer | + | Malaise | 20.2 | 8 | Arch/TA, CCA | CT, US | mPSL 80 mg |
Present case | 2022 | 48 | F | Breast cancer | + | Malaise, left neck pain | 12.65 | 14 | Arch/TA, AA, CCA | CT, US | PSL 40 mg |